Search Results - "V. N. Uppuladinne, Mallikarjunachari"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Natural plant products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute Respiratory Syndrome Coronavirus-2 by Koulgi, Shruti, Jani, Vinod, Uppuladinne V N, Mallikarjunachari, Sonavane, Uddhavesh, Joshi, Rajendra

    Published in PloS one (13-05-2021)
    “…Drug repurposing studies targeting inhibition of RNA dependent RNA polymerase (RdRP) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) have…”
    Get full text
    Journal Article
  2. 2

    Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2 by Koulgi, Shruti, Jani, Vinod, Uppuladinne, Mallikarjunachari V. N, Sonavane, Uddhavesh, Joshi, Rajendra

    Published in RSC advances (17-07-2020)
    “…The efforts towards developing a potential drug against the current global pandemic, COVID-19, have increased in the past few months. Drug development…”
    Get full text
    Journal Article
  3. 3

    A Study Modeling Bridged Nucleic Acid-Based ASOs and Their Impact on the Structure and Stability of ASO/RNA Duplexes by Dowerah, Dikshita, V. N. Uppuladinne, Mallikarjunachari, Paul, Subrata, Das, Dharitri, Gour, Nand K., Biswakarma, Nishant, Sarma, Plaban J., Sonavane, Uddhavesh B., Joshi, Rajendra R., Ray, Suvendra K., Deka, Ramesh Ch

    Published in Langmuir (15-10-2024)
    “…Antisense medications treat diseases that cannot be treated using traditional pharmacological technologies. Nucleotide monomers of bare and phosphorothioate…”
    Get full text
    Journal Article
  4. 4

    TANGO: A high through‐put conformation generation and semiempirical method‐based optimization tool for ligand molecules by Gavane, Vivek, Koulgi, Shruti, Jani, Vinod, Uppuladinne, Mallikarjunachari V. N., Sonavane, Uddhavesh, Joshi, Rajendra

    Published in Journal of computational chemistry (15-03-2019)
    “…Lead optimization is one of the crucial steps in the drug discovery pipeline. After identifying the lead molecule and obtaining its 2D geometry, understanding…”
    Get full text
    Journal Article
  5. 5

    Probing the structure of human tRNA3Lys in the presence of ligands using docking, MD simulations and MSM analysis by Mallikarjunachari V N Uppuladinne, Achalere, Archana, Sonavane, Uddhavesh, Joshi, Rajendra

    Published in RSC advances (29-08-2023)
    “…The tRNA3Lys, which acts as a primer for human immunodeficiency virus type 1 (HIV-1) reverse transcription, undergoes structural changes required for the…”
    Get full text
    Journal Article
  6. 6

    An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2–Spike complex of SARS-CoV-2 using computational methods by Jani, Vinod, Koulgi, Shruti, Uppuladinne, V. N. Mallikarjunachari, Sonavane, Uddhavesh, Joshi, Rajendra

    Published in Chemical papers (01-09-2021)
    “…The S-glycoprotein (Spike) of the SARS-CoV-2 forms a complex with the human transmembrane protein angiotensin-converting enzyme 2 (ACE2) during infection. It…”
    Get full text
    Journal Article
  7. 7

    Design of LNA Analogues Using a Combined Density Functional Theory and Molecular Dynamics Approach for RNA Therapeutics by Dowerah, Dikshita, V. N. Uppuladinne, Mallikarjunachari, Sarma, Plaban J., Biswakarma, Nishant, Sonavane, Uddhavesh B., Joshi, Rajendra R., Ray, Suvendra K., Namsa, Nima D., Deka, Ramesh Ch

    Published in ACS omega (27-06-2023)
    “…Antisense therapeutics treat a wide spectrum of diseases, many of which cannot be addressed with the current drug technologies. In the quest to design better…”
    Get full text
    Journal Article
  8. 8

    Structural insight into the binding interactions of NTPs and nucleotide analogues to RNA dependent RNA polymerase of SARS-CoV-2 by Koulgi, Shruti, Jani, Vinod, V N, Mallikarjunachari Uppuladinne, Sonavane, Uddhavesh, Joshi, Rajendra

    “…RNA dependent RNA polymerase (RdRP) from positive-stranded RNA viruses has always been a hot target for designing of new drugs. Major class of drugs that are…”
    Get full text
    Journal Article
  9. 9

    Unlocking the potential of RNAi as a therapeutic strategy against infectious viruses: an in-silico study by Uppuladinne, Mallikarjunachari V. N., Koulgi, Shruti, Jani, Vinod, Sonavane, Uddhavesh, Joshi, Rajendra

    Published in Chemical papers (01-02-2024)
    “…RNA interference is an upcoming methodology being designed to specifically target viral infections. The current study suggests a strategy to design probable…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Structural insight into antisense gapmer-RNA oligomer duplexes through molecular dynamics simulations by Uppuladinne, Mallikarjunachari V. N., Sonavane, Uddhavesh B., Deka, Ramesh Ch, Joshi, Rajendra R.

    “…There is an extensive research carrying out on antisense technology and the molecules entering into clinical trials are increasing rapidly. Phosphorothioate…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Auto-regulation of Slug mediates its activity during epithelial to mesenchymal transition by Kumar, Brijesh, Uppuladinne, Mallikarjunachari V.N., Jani, Vinod, Sonavane, Uddhavesh, Joshi, Rajendra R., Bapat, Sharmila A.

    Published in Biochimica et biophysica acta (01-09-2015)
    “…Slug, a five C2H2 zinc finger (ZF) motif transcription factor mediates cell migration in development, adult tissue repair and regeneration, as well as during…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Quantum chemical studies of novel 2′-4′ conformationally restricted antisense monomers by Uppuladinne, Mallikarjunachari V. N., Jani, Vinod, Sonavane, Uddhavesh B., Joshi, Rajendra R.

    Published in International journal of quantum chemistry (05-12-2013)
    “…The principle of antisense technologies is based on the specific inhibition of unwanted gene expression by blocking mRNA activity. A rapid increase in the…”
    Get full text
    Journal Article
  17. 17

    Structural insights into the interactions of xpt riboswitch with novel guanine analogues: a molecular dynamics simulation study by Jain, Swapan S., Sonavane, Uddhavesh B., Uppuladinne, Mallikarjunachari V.N., McLaughlin, Emily C., Wang, Weiqing, Black, Sheneil, Joshi, Rajendra R.

    “…Ligand recognition in purine riboswitches is a complex process requiring different levels of conformational changes. Recent efforts in the area of purine…”
    Get full text
    Journal Article
  18. 18

    Probing the structure of human tRNA 3 Lys in the presence of ligands using docking, MD simulations and MSM analysis by Uppuladinne, Mallikarjunachari V. N., Achalere, Archana, Sonavane, Uddhavesh, Joshi, Rajendra

    Published in RSC advances (29-08-2023)
    “…The tRNA 3 Lys , which acts as a primer for human immunodeficiency virus type 1 (HIV-1) reverse transcription, undergoes structural changes required for the…”
    Get full text
    Journal Article
  19. 19

    Probing the structure of human tRNA in the presence of ligands using docking, MD simulations and MSM analysis by Uppuladinne, Mallikarjunachari V. N, Achalere, Archana, Sonavane, Uddhavesh, Joshi, Rajendra

    Published in RSC advances (30-08-2023)
    “…The tRNA 3 Lys , which acts as a primer for human immunodeficiency virus type 1 (HIV-1) reverse transcription, undergoes structural changes required for the…”
    Get full text
    Journal Article
  20. 20

    MD simulations of HIV-1 RT primer-template complex: effect of modified nucleosides and antisense PNA oligomer by Uppuladinne, Mallikarjunachari V.N., Sonavane, Uddhavesh B., Joshi, Rajendra R.

    “…Human immunodeficiency virus type 1 (HIV-1) requires the human tRNA 3 Lys as a reverse transcriptase (RT) primer. The annealing of 3' terminal 18 nucleotides…”
    Get full text
    Journal Article